Skip to main content
. 2022 Nov 15;66:324–331. doi: 10.1016/j.breast.2022.11.005

Fig. 4.

Fig. 4

TTC in subgroups of patients from PALOMA-3 (A) with and without prior chemotherapy in ABC and (B) with nonvisceral and visceral disease (ITT population). ABC = advanced breast cancer; CT = chemotherapy; HR = hazard ratio; ITT = intent to treat; (m)TTC=(median) time to first subsequent chemotherapy.